Status | Study |
Completed |
Study Name: Platelet Function in Idiopathic Thrombocytopenic Purpura (ITP) Patients With Eltrombopag Condition: Idiopathic Thrombocytopenic Purpura Date: 2009-04-27 Interventions: Drug: eltrombopag eltrombopag |
Completed |
Study Name: Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients Condition: Idiopathic Thrombocytopenic Purpura (ITP) Date: 2009-03-10 Interventions: Drug: PG2 500mg/vial, iv infusion, 3 ~ 5 times/week, 2.5 ~ 3.5 hr/time |
Completed |
Study Name: A Study Evaluating the Addition of MabThera (Rituximab) to Standard Treatment in Patients With Idiopathic Thrombocytopenic Purpura (ITP) Condition: Idiopathic Thrombocytopenic Purpura Date: 2008-10-09 Interventions: Drug: rituximab Other Name: Ma |
Completed |
Study Name: Phase 2, Parallel Group, Rollover Study of AKR-501 in Patients With ChronicITP Who Completed 28 Days of Study Treatment in Protocol 501-CL-003 Condition: Idiopathic Thrombocytopenic Purpura Date: 2008-02-19 Interventions: Drug: Blinded (placebo) |
Completed |
Study Name: Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Condition: Chronic Idiopathic Thrombocytopenic Purpura Purpura, Thrombocyt Date: 2007-10-05 Interventions: Drug: SB-497115-GR 12.5mg SB-4 |
Completed |
Study Name: A Study to Find How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purpura (ITP) Condition: Chronic Idiopathic Thrombocytopenic Purpura Date: 2007-07-18 Interventions: Biological: Gammaplex, intravenous immunoglobulin Dosage f |
Completed |
Study Name: A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura. Condition: Idiopathic Thrombocytopenic Purpura Date: 2007-05-17 Interventions: Drug: rituximab [MabThera/Rituxan] 1000mg iv on days 1 and 15 |
Completed |
Study Name: Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura Condition: Chronic Idiopathic Thrombocytopenic Purpura Helicobacter Pylori Date: 2007-04-27 Interventions: Drug: lansoprazole, clarithromycin, amoxycillin lansoprazole (15, 30 mg) 1 tab twice daily, clarithromyc |
Completed |
Study Name: Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP) Condition: Chronic Idiopathic Thrombocytopenic Purpura Purpura, Thrombocyt Date: 2007-02-27 Interventions: Drug: Placebo Placebo Tablets |
Completed |
Study Name: Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients Condition: Idiopathic Thrombocytopenic Purpura (ITP) Date: 2006-08-09 Interventions: Drug: IgNextGen 10% Ig NextGen 10% is a liquid formulation |